The growth of novel tracers produced on a cyclotron has revolutionised molecular imaging in recent years. With advancements in radiochemistry and cyclotron technology, researchers have been able to create an expanding array of radiotracers tailored to specific biological targets and disease pathways. These novel tracers offer enhanced sensitivity and specificity, providing clinicians with valuable insights into various medical conditions, including cancer, neurological disorders, and cardiovascular diseases. Additionally, the versatility of cyclotron-produced tracers allows for the exploration of new biomarkers and therapeutic interventions, driving further innovation in personalised medicine. As demand for precise diagnostic tools and targeted therapies continues to rise, the development of novel tracers on cyclotrons is poised to play a crucial role in advancing healthcare outcomes.